NEW YORK (360Dx) – BioDirection said this week that its Tbit System for traumatic brain injury has received breakthrough device designation from the US Food and Drug Administration. The technology detects and measures protein biomarkers released from the brain immediately after head trauma and is meant to predict positive computerized tomography scans after such injuries.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.